摘要
钠通道阻断剂杀虫剂(scbis)是一个相对较新的杀虫剂,是由两个商业注册化合物类、茚虫威、氰氟虫腙。SCBIs,像pyrethroIDS和DDT,靶电压门控钠通道(VGSCs)足以让昆虫。然而,在拟除虫菊酯,不同的受体站点重叠的那些治疗SCBIs inhibit VGSCs钠通道抑制剂,如局部麻醉药,抗惊厥药和抗心律失常药。本文将叙述的SCBI杀虫类的发展从其根为几丁质合成的抑制剂,探讨中毒和证据支持抑制钠通道的作用机制的症状描述SCBI抑制VGSCs电流模型,提出了一个模型EL的受体上scbis VGSCs,突出从哺乳动物和昆虫的实验模型,收集的数据之间的差异
关键词: 电压门控钠离子通道,钠通道阻断剂杀虫剂,杀虫剂,茚虫威,statedependent通道阻断受体,杀虫剂。
Current Medicinal Chemistry
Title:Molecular Mechanism of Action and Selectivity of Sodium Ch annel Blocker Insecticides
Volume: 24 Issue: 27
关键词: 电压门控钠离子通道,钠通道阻断剂杀虫剂,杀虫剂,茚虫威,statedependent通道阻断受体,杀虫剂。
摘要: Sodium channel blocker insecticides (SCBIs) are a relatively new class of insecticides that are represented by two commercially registered compounds, indoxacarb and metaflumizone. SCBIs, like pyrethroids and DDT, target voltage-gated sodium channels (VGSCs) to intoxicate insects. In contrast to pyrethroids, however, SCBIs inhibit VGSCs at a distinct receptor site that overlaps those of therapeutic inhibitors of sodium channels, such as local anesthetics, anticonvulsants and antiarrhythmics. This review will recount the development of the SCBI insecticide class from its roots as chitin synthesis inhibitors, discuss the symptoms of poisoning and evidence supporting inhibition of VGSCs as their mechanism of action, describe the current model for SCBI-induced inhibition of VGSCs, present a model for the receptor for SCBIs on VGSCs, and highlight differences between data collected from mammalian and insect experimental models.
Export Options
About this article
Cite this article as:
Molecular Mechanism of Action and Selectivity of Sodium Ch annel Blocker Insecticides, Current Medicinal Chemistry 2017; 24 (27) . https://dx.doi.org/10.2174/0929867323666161216143844
DOI https://dx.doi.org/10.2174/0929867323666161216143844 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Histone Deacetylase Inhibitors: Therapeutic Agents and Research Tools for Deciphering Motor Neuron Diseases
Current Medicinal Chemistry α-Synuclein- and MPTP-Generated Rodent Models of Parkinsons Disease and the Study of Extracellular Striatal Dopamine Dynamics: A Microdialysis Approach
CNS & Neurological Disorders - Drug Targets Elevated Homocysteine Levels in Parkinsons Disease: Is there Anything Besides L-Dopa Treatment?
Current Medicinal Chemistry Animal Models of Narcolepsy
CNS & Neurological Disorders - Drug Targets Historical and Current Perspectives of Neuroactive Compounds Derived from Latin America
Mini-Reviews in Medicinal Chemistry Restless Legs Syndrome/Willis-Ekbom Disease and Periodic Limb Movements: A Comprehensive Review of Epidemiology, Pathophysiology, Diagnosis and Treatment Considerations
Current Rheumatology Reviews Genetic Markers in Biological Fluids for Aging-Related Major Neurocognitive Disorder
Current Alzheimer Research An Overview of Galenic Preparation Methods for Medicinal Cannabis
Current Bioactive Compounds Targeting Autophagy in the Brain: A Promising Approach?
Central Nervous System Agents in Medicinal Chemistry Potential Novel Anxiolytic Drugs
Current Pharmaceutical Design Innovations to Control the Environment for Persons with Movement Disorders: Support in Home Care
Recent Patents on Biomedical Engineering (Discontinued) Disease-Modifying Agents in the Treatment of Multiple Sclerosis: A Review of Long-Term Outcomes
CNS & Neurological Disorders - Drug Targets Clinical Implications of Recent Insights into the Structural Biology of Beta2 Adrenoceptors
Current Drug Targets Control of Copper Status for Cancer Therapy
Current Cancer Drug Targets Phenothiazines as Anti-Multi-Drug Resistant Tubercular Agents
Infectious Disorders - Drug Targets Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
Current Neuropharmacology Past, Present and Future Therapeutics for Cerebellar Ataxias
Current Neuropharmacology Resveratrol and Neurodegenerative Diseases: Activation of SIRT1 as the Potential Pathway towards Neuroprotection
Current Neurovascular Research Anti-Inflammatory Agents in Parkinsons Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Treatment Strategies for Multiple Myeloma in the Age of Novel Therapies
Current Cancer Therapy Reviews